215 related articles for article (PubMed ID: 10070874)
1. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice.
Khandelwal SR; Kavanagh BD; Lin PS; Truong QT; Lu J; Abraham DJ; Schmidt-Ullrich RK
Br J Cancer; 1999 Feb; 79(5-6):814-20. PubMed ID: 10070874
[TBL] [Abstract][Full Text] [Related]
2. RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice.
Rockwell S; Kelley M
Radiat Oncol Investig; 1998; 6(5):199-208. PubMed ID: 9822166
[TBL] [Abstract][Full Text] [Related]
3. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study.
Kleinberg L; Grossman SA; Carson K; Lesser G; O'Neill A; Pearlman J; Phillips P; Herman T; Gerber M
J Clin Oncol; 2002 Jul; 20(14):3149-55. PubMed ID: 12118029
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme.
Kleinberg L; Grossman SA; Piantadosi S; Pearlman J; Engelhard H; Lesser G; Ruffer J; Gerber M
J Clin Oncol; 1999 Aug; 17(8):2593-603. PubMed ID: 10561327
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13.
Amorino GP; Lee H; Holburn GE; Paschal CB; Hercules SK; Shyr Y; Steffen RP; Choy H
Radiat Res; 2001 Sep; 156(3):294-300. PubMed ID: 11500138
[TBL] [Abstract][Full Text] [Related]
9. Effects of carbogen plus fractionated irradiation on KHT tumor oxygenation.
Fenton BM
Radiother Oncol; 1997 Aug; 44(2):183-90. PubMed ID: 9288848
[TBL] [Abstract][Full Text] [Related]
10. The optimal combination of hyperthermia and carbogen breathing to increase tumor oxygenation and radiation response.
Griffin RJ; Okajima K; Song CW
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):865-9. PubMed ID: 9845112
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics.
Kavanagh BD; Khandelwal SR; Schmidt-Ullrich RK; Roberts JD; Shaw EG; Pearlman AD; Venitz J; Dusenbery KE; Abraham DJ; Gerber MJ
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1133-9. PubMed ID: 11240256
[TBL] [Abstract][Full Text] [Related]
12. RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass.
Kilgore KS; Shwartz CF; Gallagher MA; Steffen RP; Mosca RS; Bolling SF
Circulation; 1999 Nov; 100(19 Suppl):II351-6. PubMed ID: 10567328
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modification of hemoglobin by RSR13 as a therapeutic strategy.
Steffen RP; Liard JF; Gerber MJ; Hoffman SJ
Adv Exp Med Biol; 2003; 530():249-59. PubMed ID: 14562722
[TBL] [Abstract][Full Text] [Related]
14. Efaproxiral: a novel radiation sensitiser.
Suh JH
Expert Opin Investig Drugs; 2004 May; 13(5):543-50. PubMed ID: 15155129
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing.
Griffin RJ; Okajima K; Ogawa A; Song CW
Int J Radiat Biol; 1999 Oct; 75(10):1299-306. PubMed ID: 10549607
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole.
Suit HD; Sedlacek R; Silver G; Hsieh CC; Epp ER; Ngo FQ; Roberts WK; Verhey L
Radiat Res; 1988 Dec; 116(3):482-502. PubMed ID: 3205910
[TBL] [Abstract][Full Text] [Related]
17. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
Chaplin DJ; Horsman MR; Siemann DW
Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
[TBL] [Abstract][Full Text] [Related]
18. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation.
Khandelwal SR; Randad RS; Lin PS; Meng H; Pittman RN; Kontos HA; Choi SC; Abraham DJ; Schmidt-Ullrich R
Am J Physiol; 1993 Oct; 265(4 Pt 2):H1450-3. PubMed ID: 8238433
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
Dorie MJ; Menke D; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
[TBL] [Abstract][Full Text] [Related]
20. RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs.
Pagel PS; Hettrick DA; Montgomery MW; Kersten JR; Steffen RP; Warltier DC
J Pharmacol Exp Ther; 1998 Apr; 285(1):1-8. PubMed ID: 9535987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
